2024-03-26 2025-03-31 false Capium Accounts Production 1.1 15595268 2024-03-26 2025-03-31 15595268 bus:FullAccounts 2024-03-26 2025-03-31 15595268 bus:Micro-entities 2024-03-26 2025-03-31 15595268 bus:AuditExempt-NoAccountantsReport 2024-03-26 2025-03-31 15595268 bus:SmallCompaniesRegimeForAccounts 2024-03-26 2025-03-31 15595268 bus:PrivateLimitedCompanyLtd 2024-03-26 2025-03-31 15595268 2024-03-26 2025-03-31 15595268 2025-03-31 15595268 bus:RegisteredOffice 2024-03-26 2025-03-31 15595268 core:WithinOneYear 2025-03-31 15595268 core:AfterOneYear 2025-03-31 15595268 1 2024-03-26 2025-03-31 15595268 bus:Director1 2024-03-26 2025-03-31 15595268 bus:Director1 2025-03-31 15595268 bus:Director2 2024-03-26 2025-03-31 15595268 bus:Director2 2025-03-31 15595268 2023-03-26 15595268 bus:LeadAgentIfApplicable 2024-03-26 2025-03-31 15595268 2024-03-25 15595268 bus:OrdinaryShareClass1 2024-03-26 2025-03-31 15595268 bus:OrdinaryShareClass1 2025-03-31 15595268 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 15595268 core:CostValuation core:Non-currentFinancialInstruments 2024-03-25 15595268 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 15595268 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15595268 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15595268 core:Non-currentFinancialInstruments 2025-03-31 15595268 core:Non-currentFinancialInstruments 2024-03-25 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15595268
England and Wales

 

 

 

PATIENT SOLUTION LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 26 March 2024

End date: 31 March 2025
Directors Olatayo KOMOLAFE
Faroukh Adeshina Junior EGBEJOBI
Registered Number 15595268
Registered Office BARTLE HOUSE
9 OXFORD COURT MANCHESTER
M2 3WQ
Accountants Plusmore Ltd (T/A Plusmore Accounts)
167-169 Great Portland Street
London
W1W 5PF
1
  2025
    £ £
Current assets 135   
Creditors: amount falling due within one year (7,283)  
Net current assets   (7,148)
Total assets less current liabilities   (7,148)
Net assets   (7,148)
 

     
Total Shareholders' Funds   (7,148)
 
NOTES TO THE ACCOUNTS

General Information
PATIENT SOLUTION LIMITED is a private company, limited by shares, registered in England and Wales, registration number 15595268, registration address BARTLE HOUSE, 9 OXFORD COURT MANCHESTER, M2 3WQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the period was 0.

3.

Director’s loan

Directors’ Advances, Credits & Guarantees

Amounts owed to directors at the year end totalled £6,682. The loans are interest-free, unsecured and repayable on demand.

For the period ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 13 December 2025 and were signed on its behalf by:


--------------------------------
Olatayo KOMOLAFE
Director
2